4//SEC Filing
ANDREEFF DANE 4
Accession 0001140361-23-041885
CIK 0001610853other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 8:42 PM ET
Size
18.8 KB
Accession
0001140361-23-041885
Insider Transaction Report
Form 4
ANDREEFF DANE
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2023-08-30$7.64/sh+2,646$20,222→ 11,420 total(indirect: See footnote) - Purchase
Common Stock
2023-08-28$6.37/sh+563$3,585→ 1,820 total(indirect: See footnote) - Purchase
Common Stock
2023-08-28$6.37/sh+143$911→ 458 total(indirect: See footnote) - Purchase
Common Stock
2023-08-28$6.37/sh+2,688$17,118→ 8,774 total(indirect: See footnote) - Purchase
Common Stock
2023-08-28$6.37/sh+1,684$10,724→ 8,334 total(indirect: See footnote) - Purchase
Common Stock
2023-08-30$7.64/sh+555$4,241→ 2,375 total(indirect: See footnote) - Purchase
Common Stock
2023-08-30$7.64/sh+1,658$12,671→ 9,992 total(indirect: See footnote) - Purchase
Common Stock
2023-08-30$7.64/sh+141$1,078→ 599 total(indirect: See footnote)
Holdings
- 30
Common Stock
Footnotes (5)
- [F1]The share amount has been adjusted to reflect the reverse stock split effective on August 16, 2023 whereby each fifty shares issued and outstanding prior to the split were combined and converted into one share of common stock.
- [F2]The shares are held by Maple Leaf Partners, L.P. ("MLP"). The reporting person is the managing member of Maple Leaf Capital I, LLC ("Maple Leaf Capital"), the general partner of MLP and as such may be deemed to beneficially own the securities owned by MLP. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F3]The shares are held by Maple Leaf Partners I, L.P. ("MLP I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLP I and as such may be deemed to beneficially own the securities owned by MLP I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F4]The shares are held by Maple Leaf Discovery I, L.P. ("MLD I"). The reporting person is the managing member of Maple Leaf Capital, the general partner of MLD I and as such may be deemed to beneficially own the securities owned by MLD I. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
- [F5]The shares are held by Maple Leaf Offshore Ltd. ("MLO"). The reporting person is the president of the managing member of Andreeff Equity Advisors, L.L.C., the investment manager of MLO and as such may be deemed to beneficially own the securities owned by MLO. The reporting person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes.
Documents
Issuer
HELIUS MEDICAL TECHNOLOGIES, INC.
CIK 0001610853
Entity typeother
Related Parties
1- filerCIK 0001201810
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 8:42 PM ET
- Size
- 18.8 KB